Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
FORMA THERAPEUTICS HLDGS INC
FMTX·34633R104·US·Common Stock
FMTX (FORMA THERAPEUTICS HLDGS INC) is held by 0 institutional investors as of Q4 2022.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold FMTX.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $1.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $7.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $71,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $698,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $14M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $531,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $179.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $21.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $464,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $859,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $7.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $460,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $307,310 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $37.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $14M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $443,000 | 0.0% | — | 0 |
Showing 1-20 of 71
1 / 4
FMTXFORMA THERAPEUTICS HLDGS INCContinue exploring
Similar stocks
FISVFiserv Inc334 holders · $21.5B
SPYSPDR S&P 500 ETF Trust294 holders · $348.2B
IVViShares Core S&P 500 ETF262 holders · $566.9B
QQQInvesco QQQ Trust Series 1246 holders · $125.8B
VOOVANGUARD S&P500 INDEX ETF245 holders · $264.7B
IWMiShares Russell 2000 ETF242 holders · $68.1B
GLDSPDR GOLD TRUST GOLD SHS237 holders · $34.1B
XLFFinancial Select Sector SPDR Fund224 holders · $31.5B
XLEEnergy Select Sector SPDR Fund223 holders · $17.3B
EFAiShares MSCI EAFE ETF221 holders · $47.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer